rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Dan R. Littman

Director

Company insider

Files Form 4 as: Director, Pfizer.

In numbers

Trades disclosed
11
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
5 Mar 2018
Last trade
23 Apr 2026
Last filed
27 Apr 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
PFE PfizerDirector · Pharmaceuticals · last 23 Apr 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
23 Apr 2026filed 27 Apr 2026PFE Pfizeroption or derivative · PharmaceuticalsSEC FORM 4 Code A$205K7,686.539 at $26.67filing
23 Apr 2026filed 27 Apr 2026PFE Pfizeroption or derivative · PharmaceuticalsSEC FORM 4 Code A$205K7,686.54 at $26.67filing
24 Apr 2025filed 28 Apr 2025PFE Pfizeroption or derivative · PharmaceuticalsSEC FORM 4 Code A$205K8,999 at $22.78filing
25 Apr 2024filed 26 Apr 2024PFE Pfizeroption or derivative · PharmaceuticalsSEC FORM 4 Code A$205K8,115.6 at $25.26filing
27 Apr 2023filed 28 Apr 2023PFE Pfizeroption or derivative · PharmaceuticalsSEC FORM 4 Code A$205K5,291.69 at $38.74filing
28 Apr 2022filed 29 Apr 2022PFE Pfizeroption or derivative · PharmaceuticalsSEC FORM 4 Code A$205K4,058.6 at $50.51filing
22 Apr 2021filed 23 Apr 2021PFE Pfizeroption or derivative · PharmaceuticalsSEC FORM 4 Code A$192K4,981.88 at $38.64filing
23 Apr 2020filed 24 Apr 2020PFE Pfizeroption or derivative · PharmaceuticalsSEC FORM 4 Code A$192K5,246.66 at $36.69filing
25 Apr 2019filed 26 Apr 2019PFE Pfizeroption or derivative · PharmaceuticalsSEC FORM 4 Code A$192K4,859.88 at $39.61filing
26 Apr 2018filed 30 Apr 2018PFE Pfizeroption or derivative · PharmaceuticalsSEC FORM 4 Code A$192K5,223.88 at $36.85filing
5 Mar 2018filed 6 Mar 2018PFE Pfizeroption or derivative · PharmaceuticalsSEC FORM 4 Code A$188K5,191.03 at $36.12filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Albert BourlaChairman & CEO · Chairman & CEO at Pfizer, filing Form 4 there in the last year
Shantanu NarayenChair and CEO · Director at Pfizer, filing Form 4 there in the last year
Mortimer J. BuckleyDirector · Director at Pfizer, filing Form 4 there in the last year
Cyrus TaraporevalaDirector · Director at Pfizer, filing Form 4 there in the last year
James QuinceyDirector · Director at Pfizer, filing Form 4 there in the last year